Your browser doesn't support javascript.
loading
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II-practical challenges.
Cesano, Alessandra; Cannarile, Michael A; Gnjatic, Sacha; Gomes, Bruno; Guinney, Justin; Karanikas, Vaios; Karkada, Mohan; Kirkwood, John M; Kotlan, Beatrix; Masucci, Giuseppe V; Meeusen, Els; Monette, Anne; Naing, Aung; Thorsson, Vésteinn; Tschernia, Nicholas; Wang, Ena; Wells, Daniel K; Wyant, Timothy L; Rutella, Sergio.
Afiliación
  • Cesano A; ESSA Pharma Inc, South San Francisco, California, USA.
  • Cannarile MA; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center Munich, Penzberg, Germany.
  • Gnjatic S; Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine, New York, New York, USA.
  • Gomes B; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Basel, Switzerland.
  • Guinney J; Sage Bionetworks, Seattle, Washington, USA.
  • Karanikas V; Roche Pharmaceutical Research and Early Development Oncology, Roche Innovation Center, Zürich, Switzerland.
  • Karkada M; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts, USA.
  • Kirkwood JM; Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh School of Medicine and Melanoma Center at UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
  • Kotlan B; National Institute of Oncology, Budapest, Budapest, Hungary.
  • Masucci GV; Department Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Meeusen E; CancerProbe Pty Ltd, Prahran, Victoria, Australia.
  • Monette A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.
  • Naing A; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Thorsson V; Institute for Systems Biology, Seattle, Washington, USA.
  • Tschernia N; Department of Medicine, Division of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Wang E; Allogene Therapeutics, South San Francisco, California, USA.
  • Wells DK; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA.
  • Wyant TL; Biolojic Design Inc, Cambridge, Massachusetts, USA.
  • Rutella S; John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, Nottinghamshire, UK sergio.rutella@ntu.ac.uk.
J Immunother Cancer ; 8(2)2020 12.
Article en En | MEDLINE | ID: mdl-33323463
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Inmunoterapia Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Inmunoterapia Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos